Article
The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.
Journal of molecular biology - 25 Jun 2004
Levy Yaakov, Caflisch Amedeo, Onuchic Jose N, Wolynes Peter G
Abstract excerpt
HIV-1 protease (PR) is a major drug target in combating AIDS, as it plays a key role in maturation and replication of the virus. Six FDA-approved drugs are currently in clinical use, all designed to inhibit enzyme activity by blocking the active site, which exists only in the dimer. An alternative inhibition mode would be required to overcome the emergence of drug-resistance through the accumulation of mutations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
